1 Min Read
May 24 (Reuters) - Novartis AG :
* Sandoz’ biosimilar rituximab regulatory submission accepted by European Medicines Agency Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.